)
Citius Pharmaceuticals (CTXR) investor relations material
Citius Pharmaceuticals Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Seven directors are nominated for election to serve until the 2027 annual meeting or until successors are elected and qualified.
Ratification of Wolf & Company, P.C. as the independent auditor for the fiscal year ending September 30, 2026 is proposed.
Additional business may be transacted as may properly come before the meeting or any adjournment.
Board of directors and corporate governance
The board recommends voting in favor of all director nominees and the auditor ratification.
Audit committee and external auditor matters
Wolf & Company, P.C. is proposed for ratification as the independent registered public accounting firm for the next fiscal year.
- Shareholders will elect directors, ratify the auditor, and review executive compensation and governance.CTXR
Proxy Filing24 Feb 2026 - LYMPHIR launch drove $3.94M revenue, 80% margin, narrowing net loss but cash needs remain.CTXR
Q1 202613 Feb 2026 - FDA approval of LYMPHIR and Citius Oncology spin-off drive transition to commercial-stage growth.CTXR
Investor Update2 Feb 2026 - FDA approval, pipeline momentum, and a strategic spin-off drive growth and new revenue streams.CTXR
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - LYMPHIR approved and spun off, with commercialization and share distribution planned for 2025.CTXR
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Lymphir launches in January 2025, with Mino-Lok and new trials driving growth.CTXR
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - LYMPHIR's U.S. launch marks a pivotal year, with strong capital raises and ongoing pipeline progress.CTXR
Q4 202523 Dec 2025 - Key votes include director elections, share authorization increase, and auditor ratification.CTXR
Proxy Filing2 Dec 2025 - Key votes include board elections, executive pay, and a tenfold increase in authorized shares.CTXR
Proxy Filing2 Dec 2025
Next Citius Pharmaceuticals earnings date
Next Citius Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)